期刊文献+

麻杏石甘汤治疗社区获得性肺炎肺热型疗效评价及对血清降钙素原的影响 被引量:23

Effi cacy evaluation of Maxing Shigan Decoction on community acquired pneumonia and its infl uence on serum procalcitonin
原文传递
导出
摘要 目的:观察麻杏石甘汤治疗社区获得性肺炎肺热型的临床疗效及对血清降钙素原(PCT)的影响。方法:将100例社区获得性肺炎患者随机分为治疗组51例、对照组49例,治疗组予基础治疗+麻杏石甘汤每次100mL,每日2次口服;对照组予基础治疗。治疗10d后评价两组临床疗效并监测PCT的变化。结果:两组总疗效、中医证候疗效、总满意率比较,差异有统计学意义(P<0.05,P<0.01),治疗组优于对照组。治疗组体温稳定时间,咳嗽、气急、双肺啰音消失天数,平均治愈天数,X线示炎症吸收天数与对照组比较,差异有统计学意义(P<0.01,P<0.05),治疗组疗效优于对照组。治疗后治疗组中医证候部分指标积分,治疗后5d血常规中白细胞、血PCT与对照组比较,差异有统计学意义(P<0.05,P<0.01),治疗组疗效优于对照组。结论:麻杏石甘汤治疗社区获得性肺炎肺热型疗效肯定,患者满意度高,且对PCT有明显降低作用。 Objective: To observe the efficacy evaluation of Maxing Shigan Decoction on community acquired pneumonia (CAP) and its influence on serum procalcitonin. Methods: A total of 100 CAP patients were randomly divided into a treatment group (51 cases) and a control group (49 cases). The treatment group was treated with basic therapy and 100mL of Maxing Shigan DecoCtion twice a day, while the control group was treated with basic therapy. After treatment for 10 days, the clinical efficacies of two groups were evaluated and the changes of serum procalcitonin were monitored. Results: Compared the treatment group with the control group, the total efficiency rate, the efficiency rate of TCM syndrome, the total satisfaction rate were statistically significantly different (P〈0.05, P〈0.01), and the treatment group was superior to the control group. After treatment, time needed for body temperature to stabilize, the number of the days needed for coughing, shortness of breath, and rale to disappear, the average number of the days to cure, and the number of inflammation absorption days (shown with X line) had statistical significance between the two groups (P〈0.01, P〈0.05), and the treatment group was superior to the control group. After treatment, the Chinese medicine symptom scores, WBC and PCT were better in the treatment group and they had statistical significance between the two groups (P〈0.05, P〈0.01). The treatment group was superior to the control group. Conclusion: Maxing Shigan Decoction has a curative effect on CAP and it could decrease serum procalcitonin markedly. Patients are highly satisfied with this prescription.
作者 李颖 张纾难
机构地区 中日友好医院
出处 《中华中医药杂志》 CAS CSCD 北大核心 2014年第4期1272-1275,共4页 China Journal of Traditional Chinese Medicine and Pharmacy
关键词 社区获得性肺炎 麻杏石甘汤 临床疗效 降钙素原 , Community acquired pneumonia Maxing Shigan Decoction Therapeutic effect Serum procalcitonin
  • 相关文献

参考文献7

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3050
  • 2王永炎主编..中医内科学[M].上海:上海科学技术出版社,1997:388.
  • 3SFDA.中药新药临床研究指导原则.北京:中国医药科技出版社.2002:390-391. 被引量:66
  • 4中华医学会,中华医院管理学会药事管理专业委员会,中国药学会医院药学专业委员会.抗菌药物临床应用指导原则[J].中华医学杂志,2004,84(23):2026-2056. 被引量:141
  • 5Redl H,Schlag G, Ttigel E,et al.Procalcitonin release patterns in a baboon model of trauma and sepsis:relationship to cytokinesand neopterin.Crit Care Med,2000,28(11):3659-3663. 被引量:1
  • 6Vouloumanou E K,Plessa E,Karageorgopoulos D E,et al.Serum procalcitonin as a diagnostic marker for neonatal sepsis:a systematic i'evlew Care Med,2011,3(5):201-204. 被引量:1
  • 7Levy M M,Fink M P,Marshall J C,et al.2001 SCCM/ESICM/ ACCP,ATS/SISintemational sepsisdefinitions conference.CritCare Med,2003,31(5):1250-1256. 被引量:1

二级参考文献24

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:787
  • 3Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153. 被引量:1
  • 4de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351. 被引量:1
  • 5Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659. 被引量:1
  • 6Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936. 被引量:1
  • 7Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421. 被引量:1
  • 8Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180. 被引量:1
  • 9Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433. 被引量:1
  • 10Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250. 被引量:1

共引文献3240

同被引文献295

引证文献23

二级引证文献324

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部